ID   NDKA_HUMAN              Reviewed;         152 AA.
AC   P15531; Q6FGK3; Q86XQ2; Q9UDJ6;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   10-MAY-2017, entry version 200.
DE   RecName: Full=Nucleoside diphosphate kinase A;
DE            Short=NDK A;
DE            Short=NDP kinase A;
DE            EC=2.7.4.6;
DE   AltName: Full=Granzyme A-activated DNase;
DE            Short=GAAD;
DE   AltName: Full=Metastasis inhibition factor nm23;
DE   AltName: Full=NM23-H1;
DE   AltName: Full=Tumor metastatic process-associated protein;
GN   Name=NME1; Synonyms=NDPKA, NM23;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2509941; DOI=10.1038/342177a0;
RA   Rosengard A.M., Krutzsch H.C., Shearn A., Biggs J.R., Barker E.,
RA   Margulies I.M.K., King C.R., Liotta L.A., Steeg P.S.;
RT   "Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila
RT   development.";
RL   Nature 342:177-180(1989).
RN   [2]
RP   PROTEIN SEQUENCE (ISOFORM 1), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=1851158;
RA   Gilles A.-M., Presecan E., Vonica A., Lascu I.;
RT   "Nucleoside diphosphate kinase from human erythrocytes. Structural
RT   characterization of the two polypeptide chains responsible for
RT   heterogeneity of the hexameric enzyme.";
RL   J. Biol. Chem. 266:8784-8789(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7916650;
RA   Wang L., Patel U., Ghosh L., Chen H.C., Banerjee S.;
RT   "Mutation in the nm23 gene is associated with metastasis in colorectal
RT   cancer.";
RL   Cancer Res. 53:717-720(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=8270257; DOI=10.1007/BF00218915;
RA   Dooley S., Seib T., Engel M., Theisinger B., Janz H., Piontek K.,
RA   Zang K.D., Welter C.;
RT   "Isolation and characterization of the human genomic locus coding for
RT   the putative metastasis control gene nm23-H1.";
RL   Hum. Genet. 93:63-66(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12601555; DOI=10.1007/s100380300014;
RA   Ni X., Gu S., Dai J., Cheng H., Guo L., Li L., Ji C., Xie Y., Ying K.,
RA   Mao Y.;
RT   "Isolation and characterization of a novel human NM23-H1B gene, a
RT   different transcript of NM23-H1.";
RL   J. Hum. Genet. 48:96-100(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 7-18; 40-49 AND 89-94 (ISOFORMS 1/2), AND
RP   DISCUSSION OF THE ROLE IN TUMOR PROGRESSION.
RC   TISSUE=Neuroblastoma;
RX   PubMed=2056128; DOI=10.1172/JCI115299;
RA   Hailat N., Keim D.R., Melhem R.F., Zhu X.X., Eckerskorn C.,
RA   Brodeur G.M., Reynolds C.P., Seeger R.C., Lottspeich F.,
RA   Strahler J.R., Hanash S.J.;
RT   "High levels of p19/nm23 protein in neuroblastoma are associated with
RT   advanced stage disease and with N-myc gene amplification.";
RL   J. Clin. Invest. 88:341-345(1991).
RN   [12]
RP   PROTEIN SEQUENCE OF 7-26; 40-49; 57-85 AND 89-128 (ISOFORMS 1/2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF PRO-96; HIS-118 AND SER-120.
RX   PubMed=8810265; DOI=10.1074/jbc.271.41.25107;
RA   MacDonald N.J., Freije J.M., Stracke M.L., Manrow R.E., Steeg P.S.;
RT   "Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or
RT   serine 120 abrogates its motility inhibitory activity upon
RT   transfection into human breast carcinoma cells.";
RL   J. Biol. Chem. 271:25107-25116(1996).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=10512675; DOI=10.1006/geno.1999.5939;
RA   Manda R., Kohno T., Matsuno Y., Takenoshita S., Kuwano H., Yokota J.;
RT   "Identification of genes (SPON2 and C20orf2) differentially expressed
RT   between cancerous and noncancerous lung cells by mRNA differential
RT   display.";
RL   Genomics 61:5-14(1999).
RN   [15]
RP   FUNCTION, ENZYME REGULATION, INTERACTION WITH SET, AND IDENTIFICATION
RP   IN THE SET COMPLEX.
RX   PubMed=12628186; DOI=10.1016/S0092-8674(03)00150-8;
RA   Fan Z., Beresford P.J., Oh D.Y., Zhang D., Lieberman J.;
RT   "Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-
RT   mediated apoptosis, and the nucleosome assembly protein SET is its
RT   inhibitor.";
RL   Cell 112:659-672(2003).
RN   [16]
RP   ALTERNATIVE SPLICING (ISOFORM 3), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16442775; DOI=10.1016/j.ygeno.2005.11.004;
RA   Valentijn L.J., Koster J., Versteeg R.;
RT   "Read-through transcript from NM23-H1 into the neighboring NM23-H2
RT   gene encodes a novel protein, NM23-LV.";
RL   Genomics 87:483-489(2006).
RN   [17]
RP   FUNCTION, INTERACTION WITH TREX1, AND IDENTIFICATION IN THE SET
RP   COMPLEX.
RX   PubMed=16818237; DOI=10.1016/j.molcel.2006.06.005;
RA   Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.S., Demple B.,
RA   Perrino F.W., Lieberman J.;
RT   "The exonuclease TREX1 is in the SET complex and acts in concert with
RT   NM23-H1 to degrade DNA during granzyme A-mediated cell death.";
RL   Mol. Cell 23:133-142(2006).
RN   [18]
RP   INTERACTION WITH PRUNE1.
RX   PubMed=17906697; DOI=10.1038/sj.onc.1210822;
RA   Garzia L., D'Angelo A., Amoresano A., Knauer S.K., Cirulli C.,
RA   Campanella C., Stauber R.H., Steegborn C., Iolascon A., Zollo M.;
RT   "Phosphorylation of nm23-H1 by CKI induces its complex formation with
RT   h-prune and promotes cell motility.";
RL   Oncogene 27:1853-1864(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120; SER-122 AND
RP   SER-125, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=11835509; DOI=10.1002/prot.10038;
RA   Min K., Song H.K., Chang C., Kim S.Y., Lee K.J., Suh S.W.;
RT   "Crystal structure of human nucleoside diphosphate kinase A, a
RT   metastasis suppressor.";
RL   Proteins 46:340-342(2002).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND MUTAGENESIS OF PHE-60 AND
RP   HIS-118.
RX   PubMed=12972261; DOI=10.1016/j.jmb.2003.07.004;
RA   Chen Y., Gallois-Montbrun S., Schneider B., Veron M., Morera S.,
RA   Deville-Bonne D., Janin J.;
RT   "Nucleotide binding to nucleoside diphosphate kinases: X-ray structure
RT   of human NDPK-A in complex with ADP and comparison to protein
RT   kinases.";
RL   J. Mol. Biol. 332:915-926(2003).
RN   [25]
RP   VARIANT GLY-120.
RX   PubMed=8047138; DOI=10.1038/370335a0;
RA   Chang C.L., Zhu X.-X., Thoraval D.H., Ungar D., Rawwas J., Hora N.,
RA   Strahler J.R., Hanash S.M.;
RT   "Nm23-H1 mutation in neuroblastoma.";
RL   Nature 370:335-336(1994).
CC   -!- FUNCTION: Major role in the synthesis of nucleoside triphosphates
CC       other than ATP. The ATP gamma phosphate is transferred to the NDP
CC       beta phosphate via a ping-pong mechanism, using a phosphorylated
CC       active-site intermediate. Possesses nucleoside-diphosphate kinase,
CC       serine/threonine-specific protein kinase, geranyl and farnesyl
CC       pyrophosphate kinase, histidine protein kinase and 3'-5'
CC       exonuclease activities. Involved in cell proliferation,
CC       differentiation and development, signal transduction, G protein-
CC       coupled receptor endocytosis, and gene expression. Required for
CC       neural development including neural patterning and cell fate
CC       determination. During GZMA-mediated cell death, works in concert
CC       with TREX1. NME1 nicks one strand of DNA and TREX1 removes bases
CC       from the free 3' end to enhance DNA damage and prevent DNA end
CC       reannealing and rapid repair. {ECO:0000269|PubMed:12628186,
CC       ECO:0000269|PubMed:16818237, ECO:0000269|PubMed:8810265}.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Autophosphorylation at His-118 increases
CC       serine/threonine protein kinase activity of the enzyme.
CC       Interaction with the SET complex inhibits the endonuclease
CC       activity. {ECO:0000269|PubMed:12628186}.
CC   -!- SUBUNIT: Hexamer of two different chains: A and B (A6, A5B, A4B2,
CC       A3B3, A2B4, AB5, B6). Interacts with PRUNE1. Component of the SET
CC       complex, composed of at least ANP32A, APEX1, HMGB2, NME1, SET and
CC       TREX1. Within this complex, interacts directly with SET. Also
CC       interacts with TREX1, but only following translocation to the
CC       nucleus. {ECO:0000269|PubMed:12628186,
CC       ECO:0000269|PubMed:16818237, ECO:0000269|PubMed:17906697,
CC       ECO:0000269|PubMed:1851158}.
CC   -!- INTERACTION:
CC       Self; NbExp=12; IntAct=EBI-741141, EBI-741141;
CC       Q61097:Ksr1 (xeno); NbExp=7; IntAct=EBI-741141, EBI-1536336;
CC       P10911:MCF2; NbExp=4; IntAct=EBI-741141, EBI-1914514;
CC       P22392:NME2; NbExp=2; IntAct=EBI-741141, EBI-713693;
CC       Q13232:NME3; NbExp=4; IntAct=EBI-741141, EBI-713684;
CC       O00746:NME4; NbExp=6; IntAct=EBI-741141, EBI-744871;
CC       Q7Z2X4:PID1; NbExp=3; IntAct=EBI-741141, EBI-10256685;
CC       O15160:POLR1C; NbExp=7; IntAct=EBI-741141, EBI-1055079;
CC       Q86TP1:PRUNE; NbExp=2; IntAct=EBI-741141, EBI-2127112;
CC       Q8N9Q2:SREK1IP1; NbExp=3; IntAct=EBI-741141, EBI-10268630;
CC       Q9Y3F4:STRAP; NbExp=9; IntAct=EBI-741141, EBI-727414;
CC       O14787:TNPO2; NbExp=3; IntAct=EBI-741141, EBI-431907;
CC       Q96HA8:WDYHV1; NbExp=5; IntAct=EBI-741141, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16442775}.
CC       Nucleus {ECO:0000269|PubMed:16442775}. Note=Cell-cycle dependent
CC       nuclear localization which can be induced by interaction with
CC       Epstein-barr viral proteins or by degradation of the SET complex
CC       by GzmA.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=NM23-H1A;
CC         IsoId=P15531-1; Sequence=Displayed;
CC       Name=2; Synonyms=NM23-H1B;
CC         IsoId=P15531-2; Sequence=VSP_036707;
CC       Name=3; Synonyms=NM23-LV;
CC         IsoId=P22392-2; Sequence=External;
CC         Note=Based on a naturally occurring readthrough transcript which
CC         produces an NME1-NME2 fusion protein.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in heart, brain,
CC       placenta, lung, liver, skeletal muscle, pancreas, spleen and
CC       thymus. Expressed in lung carcinoma cell lines but not in normal
CC       lung tissues. Isoform 2 is ubiquitously expressed and its
CC       expression is also related to tumor differentiation.
CC       {ECO:0000269|PubMed:10512675, ECO:0000269|PubMed:12601555,
CC       ECO:0000269|PubMed:16442775}.
CC   -!- MISCELLANEOUS: The role of this protein in tumor development and
CC       progression is uncertain. This protein is found in reduced amount
CC       in some tumor cells of high metastatic potential. However,
CC       increased NME1 levels correlate with aggressive tumor features in
CC       neuroblastoma. May have distinct if not opposite roles in
CC       different tumors.
CC   -!- SIMILARITY: Belongs to the NDK family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA35621.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17620; CAA35621.1; ALT_INIT; mRNA.
DR   EMBL; X73066; CAA51527.1; -; mRNA.
DR   EMBL; X75598; CAA53270.1; -; Genomic_DNA.
DR   EMBL; AF487339; AAO85436.1; -; mRNA.
DR   EMBL; AK291105; BAF83794.1; -; mRNA.
DR   EMBL; CR542104; CAG46901.1; -; mRNA.
DR   EMBL; CR542115; CAG46912.1; -; mRNA.
DR   EMBL; AC005839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94568.1; -; Genomic_DNA.
DR   EMBL; BC000293; AAH00293.1; -; mRNA.
DR   EMBL; BC018994; AAH18994.1; -; mRNA.
DR   CCDS; CCDS11578.1; -. [P15531-2]
DR   CCDS; CCDS11579.1; -. [P15531-1]
DR   PIR; A33386; A33386.
DR   RefSeq; NP_000260.1; NM_000269.2. [P15531-1]
DR   RefSeq; NP_937818.1; NM_198175.1. [P15531-2]
DR   UniGene; Hs.463456; -.
DR   PDB; 1JXV; X-ray; 2.20 A; A/B/C/D/E/F=1-152.
DR   PDB; 1UCN; X-ray; 2.00 A; A/B/C=1-152.
DR   PDB; 2HVD; X-ray; 2.15 A; A/B/C=1-152.
DR   PDB; 2HVE; X-ray; 2.40 A; A/B/C=1-152.
DR   PDB; 3L7U; X-ray; 2.10 A; A/B/C=1-152.
DR   PDB; 4ENO; X-ray; 2.80 A; A/B=1-152.
DR   PDBsum; 1JXV; -.
DR   PDBsum; 1UCN; -.
DR   PDBsum; 2HVD; -.
DR   PDBsum; 2HVE; -.
DR   PDBsum; 3L7U; -.
DR   PDBsum; 4ENO; -.
DR   ProteinModelPortal; P15531; -.
DR   SMR; P15531; -.
DR   BioGrid; 110894; 58.
DR   DIP; DIP-39164N; -.
DR   IntAct; P15531; 29.
DR   MINT; MINT-221462; -.
DR   STRING; 9606.ENSP00000013034; -.
DR   ChEMBL; CHEMBL2159; -.
DR   DrugBank; DB03491; 2'-Deoxyguanosine-5'-Diphosphate.
DR   DrugBank; DB02181; 2'-Deoxyguanosine-5'-Triphosphate.
DR   DrugBank; DB04542; 3'-Azido-3'-Deoxythymidine-5'-Diphosphate.
DR   DrugBank; DB04366; 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate.
DR   DrugBank; DB00718; Adefovir Dipivoxil.
DR   DrugBank; DB02607; Adenosine Phosphonoacetic Acid.
DR   DrugBank; DB04068; Fudp.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB00709; Lamivudine.
DR   DrugBank; DB02345; Selenocysteine.
DR   DrugBank; DB00300; Tenofovir.
DR   DrugBank; DB03103; Thymidine-5'- Diphosphate.
DR   iPTMnet; P15531; -.
DR   PhosphoSitePlus; P15531; -.
DR   SwissPalm; P15531; -.
DR   BioMuta; NME1; -.
DR   DMDM; 127981; -.
DR   DOSAC-COBS-2DPAGE; P15531; -.
DR   OGP; P15531; -.
DR   EPD; P15531; -.
DR   PaxDb; P15531; -.
DR   PeptideAtlas; P15531; -.
DR   PRIDE; P15531; -.
DR   TopDownProteomics; P15531-1; -. [P15531-1]
DR   DNASU; 4830; -.
DR   Ensembl; ENST00000013034; ENSP00000013034; ENSG00000239672. [P15531-2]
DR   Ensembl; ENST00000336097; ENSP00000337060; ENSG00000239672. [P15531-2]
DR   Ensembl; ENST00000393196; ENSP00000376892; ENSG00000239672. [P15531-1]
DR   GeneID; 4830; -.
DR   KEGG; hsa:4830; -.
DR   UCSC; uc002ith.3; human. [P15531-1]
DR   CTD; 4830; -.
DR   DisGeNET; 4830; -.
DR   GeneCards; NME1; -.
DR   HGNC; HGNC:7849; NME1.
DR   HPA; CAB040571; -.
DR   HPA; HPA008467; -.
DR   HPA; HPA041113; -.
DR   MalaCards; NME1; -.
DR   MIM; 156490; gene.
DR   neXtProt; NX_P15531; -.
DR   OpenTargets; ENSG00000239672; -.
DR   PharmGKB; PA249; -.
DR   eggNOG; KOG0888; Eukaryota.
DR   eggNOG; COG0105; LUCA.
DR   GeneTree; ENSGT00760000119146; -.
DR   HOGENOM; HOG000224564; -.
DR   HOVERGEN; HBG000423; -.
DR   InParanoid; P15531; -.
DR   KO; K00940; -.
DR   OMA; VERFFME; -.
DR   OrthoDB; EOG091G0PLD; -.
DR   PhylomeDB; P15531; -.
DR   TreeFam; TF106373; -.
DR   BioCyc; MetaCyc:ENSG00000011052-MONOMER; -.
DR   BRENDA; 2.7.4.6; 2681.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   SIGNOR; P15531; -.
DR   ChiTaRS; NME1; human.
DR   EvolutionaryTrace; P15531; -.
DR   GeneWiki; NME1; -.
DR   GenomeRNAi; 4830; -.
DR   PRO; PR:P15531; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000239672; -.
DR   CleanEx; HS_NME1; -.
DR   ExpressionAtlas; P15531; baseline and differential.
DR   Genevisible; P15531; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004536; F:deoxyribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0043024; F:ribosomal small subunit binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006241; P:CTP biosynthetic process; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0006183; P:GTP biosynthetic process; IEA:InterPro.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:HGNC.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0006228; P:UTP biosynthetic process; IEA:InterPro.
DR   HAMAP; MF_00451; NDP_kinase; 1.
DR   InterPro; IPR001564; Nucleoside_diP_kinase.
DR   InterPro; IPR023005; Nucleoside_diP_kinase_AS.
DR   Pfam; PF00334; NDK; 1.
DR   PRINTS; PR01243; NUCDPKINASE.
DR   SMART; SM00562; NDK; 1.
DR   PROSITE; PS00469; NDP_KINASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Differentiation; Direct protein sequencing; Endocytosis;
KW   Isopeptide bond; Kinase; Magnesium; Metal-binding; Neurogenesis;
KW   Nucleotide metabolism; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P52174}.
FT   CHAIN         2    152       Nucleoside diphosphate kinase A.
FT                                /FTId=PRO_0000137114.
FT   ACT_SITE    118    118       Pros-phosphohistidine intermediate.
FT                                {ECO:0000269|PubMed:1851158}.
FT   BINDING      12     12       ATP.
FT   BINDING      60     60       ATP.
FT   BINDING      88     88       ATP.
FT   BINDING      94     94       ATP.
FT   BINDING     105    105       ATP.
FT   BINDING     115    115       ATP.
FT   MOD_RES     120    120       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    100    100       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VAR_SEQ       1      1       M -> MVLLSTLGIVFQGEGPPISSCDTGTM (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:12601555}.
FT                                /FTId=VSP_036707.
FT   VARIANT     120    120       S -> G (in a neuroblastoma sample;
FT                                increased motility of carcinoma cells;
FT                                dbSNP:rs121917887).
FT                                {ECO:0000269|PubMed:8047138}.
FT                                /FTId=VAR_004625.
FT   MUTAGEN      60     60       F->W: No loss of activity or substrate
FT                                binding. {ECO:0000269|PubMed:12972261}.
FT   MUTAGEN      96     96       P->S: Increased motility of carcinoma
FT                                cells. {ECO:0000269|PubMed:8810265}.
FT   MUTAGEN     118    118       H->F: Loss of serine/threonine kinase
FT                                activity. Some loss of motility of
FT                                carcinoma cells.
FT                                {ECO:0000269|PubMed:12972261,
FT                                ECO:0000269|PubMed:8810265}.
FT   MUTAGEN     118    118       H->G: Loss of activity.
FT                                {ECO:0000269|PubMed:12972261,
FT                                ECO:0000269|PubMed:8810265}.
FT   MUTAGEN     120    120       S->A: Limited increase in motility of
FT                                carcinoma cells.
FT                                {ECO:0000269|PubMed:8810265}.
FT   HELIX         2      4       {ECO:0000244|PDB:3L7U}.
FT   STRAND        6     11       {ECO:0000244|PDB:1UCN}.
FT   HELIX        13     17       {ECO:0000244|PDB:1UCN}.
FT   HELIX        21     31       {ECO:0000244|PDB:1UCN}.
FT   STRAND       34     41       {ECO:0000244|PDB:1UCN}.
FT   HELIX        45     51       {ECO:0000244|PDB:1UCN}.
FT   HELIX        53     55       {ECO:0000244|PDB:1UCN}.
FT   STRAND       56     58       {ECO:0000244|PDB:4ENO}.
FT   HELIX        61     69       {ECO:0000244|PDB:1UCN}.
FT   STRAND       73     80       {ECO:0000244|PDB:1UCN}.
FT   HELIX        83     91       {ECO:0000244|PDB:1UCN}.
FT   HELIX        96     98       {ECO:0000244|PDB:1UCN}.
FT   HELIX       104    108       {ECO:0000244|PDB:1UCN}.
FT   HELIX       112    114       {ECO:0000244|PDB:1UCN}.
FT   STRAND      116    119       {ECO:0000244|PDB:1UCN}.
FT   HELIX       123    133       {ECO:0000244|PDB:1UCN}.
FT   HELIX       136    138       {ECO:0000244|PDB:1UCN}.
FT   HELIX       147    150       {ECO:0000244|PDB:1UCN}.
SQ   SEQUENCE   152 AA;  17149 MW;  AAE9C0DF63CB70A1 CRC64;
     MANCERTFIA IKPDGVQRGL VGEIIKRFEQ KGFRLVGLKF MQASEDLLKE HYVDLKDRPF
     FAGLVKYMHS GPVVAMVWEG LNVVKTGRVM LGETNPADSK PGTIRGDFCI QVGRNIIHGS
     DSVESAEKEI GLWFHPEELV DYTSCAQNWI YE
//
